ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)
CUSIP: 04280A100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 135,488,140
- Total 13F shares
- 105,716,035
- Share change
- +2,396,724
- Total reported value
- $1,671,181,802
- Put/Call ratio
- 128%
- Price per share
- $15.80
- Number of holders
- 279
- Value change
- +$44,748,514
- Number of buys
- 153
- Number of sells
- 117
Quarterly Holders Quick Answers
What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04280A100:
Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
15%
|
19,926,154
|
$253,859,202 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
8.3%
|
11,517,441
|
$193,377,834 | -$8,581,554 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
13,202,562
|
$168,200,640 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
4.6%
|
6,371,056
|
$106,970,030 | -$10,547,360 | 30 Jun 2025 | |
| Slate Path Capital LP |
13F
|
Company |
3.9%
|
5,232,000
|
$66,655,680 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
3.5%
|
4,785,062
|
$60,961,689 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.4%
|
3,315,082
|
$42,234,145 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,950,312
|
$37,595,616 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
2%
|
2,669,880
|
$34,014,271 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.9%
|
2,528,982
|
$32,220,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,848,536
|
$23,550,350 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,741,666
|
$22,188,824 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
1,626,563
|
$20,722,414 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.89%
|
1,210,813
|
$15,425,757 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.79%
|
1,072,827
|
$13,667,816 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
1,035,290
|
$13,189,595 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.73%
|
986,951
|
$12,573,756 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.62%
|
835,174
|
$10,640,117 | — | 31 Mar 2025 | |
| Western Financial Corp/CA |
13F
|
Company |
0.61%
|
820,239
|
$10,449,845 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.59%
|
798,200
|
$10,169,070 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
776,039
|
$9,886,740 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
723,800
|
$9,221,212 | — | 31 Mar 2025 | |
| Kenneth Allen Myszkowski |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
455,433
|
$8,967,476 | — | 04 Jan 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.51%
|
690,796
|
$8,800,741 | — | 31 Mar 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.46%
|
629,214
|
$8,016,186 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.46%
|
629,075
|
$8,014,416 | — | 31 Mar 2025 | |
| Javier San Martin |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
198,497
|
$7,417,833 | — | 04 Jan 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.41%
|
562,175
|
$7,162,110 | — | 31 Mar 2025 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.41%
|
550,130
|
$7,008,656 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.36%
|
487,671
|
$6,212,929 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.36%
|
483,253
|
$6,156,641 | — | 31 Mar 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.34%
|
459,854
|
$5,858,541 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.3%
|
399,870
|
$5,094,344 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.29%
|
395,114
|
$5,033,753 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.26%
|
345,979
|
$4,407,744 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.25%
|
337,878
|
$4,304,565 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
327,310
|
$4,169,929 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.23%
|
314,080
|
$4,001,380 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.21%
|
288,030
|
$3,965,223 | — | 31 Mar 2025 | |
| James Hassard |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
105,750
|
$3,951,878 | — | 22 Jun 2021 | |
| Edgestream Partners, L.P. |
13F
|
Company |
0.23%
|
305,507
|
$3,892,159 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
289,376
|
$3,686,650 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
286,231
|
$3,646,583 | — | 31 Mar 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.21%
|
279,749
|
$3,564,002 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.2%
|
277,550
|
$3,535,987 | — | 31 Mar 2025 | |
| Tracie Oliver |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
127,107
|
$3,213,265 | — | 02 Jul 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.18%
|
249,989
|
$3,184,860 | — | 31 Mar 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.18%
|
247,598
|
$3,154,399 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.18%
|
240,175
|
$3,059,830 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.18%
|
238,328
|
$3,045,992 | — | 31 Mar 2025 |
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q2 2025
As of 30 Jun 2025,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,716,035 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Slate Path Capital LP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, Siren, L.L.C., and MARSHALL WACE, LLP.
This page lists
279
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
258
Q2 2025 holders
279
Holder diff
21
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.